
Lalvin Pharma Private Limited
About Lalvin Pharma Private Limited
Data last updated:
Lalvin Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 31 May 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2021PTC151869.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹50,000. It is led by directors Vinay Kumar and Aryan Raza.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No – 31 D Tripura Landmark 2 Bowrampet, Hyderabad, Telangana, India – 500043.
As per the financials filed for FY 2025, the company reported a revenue of ₹52.4 Lakh, a growth of 44% compared to the previous year. For the same year it recorded a net profit of ₹16,503 (net margin 0.3%) and EBITDA of ₹42,774 (EBITDA margin 0.8%).
Company details
Contact details
Lalvin Pharma Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressPlot No – 31 D Tripura Landmark 2 Bowrampet, Hyderabad, Telangana, India – 500043
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lalvin Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Lalvin Pharma Private Limited, buy the company report.
Financials of Lalvin Pharma Private Limited
FY 2025 filings availableLalvin Pharma Private Limited reported revenue of ₹52.4 Lakh (up 44% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 44% in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹42,774 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹16,503 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0.8% | |||
| Net Profit Margin | 0.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Lalvin Pharma Private Limited, buy the company report.
Board of directors of Lalvin Pharma Private Limited
Lalvin Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinay Kumar | Director | 31 May 2021 | 5 Years 5 Months | Current |
| Aryan Raza | Director | 01 Dec 2023 | 2 Years 11 Months | Current |
Peer comparison
Lalvin Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mod Steel Trade Private Limited | ₹52.53 Lakh (FY 2025) | 45.0% | Mumbai, Maharashtra, India | |||
| Tradetrail International Private Limited | ₹52.52 Lakh (FY 2025) | Kolkata, West Bengal, India | ||||
| Rayanna Sheep and Goat Farmers Producer Company Limited | ₹52.51 Lakh (FY 2025) | -46.0% | Mudalagi, Karnataka, India | |||
| Aren Capsules Private Limited | ₹52.44 Lakh (FY 2025) | -72.0% | New Delhi, Delhi, India | |||
| Red Sand Holidays Private Limited | ₹52.4 Lakh (FY 2025) | -93.0% | Jaipur, Rajasthan, India | |||
| Lalvin Pharma Private Limitedthis company | ₹52.4 Lakh (FY 2025) | ₹16,503 | 0.3% | 44.0% | Hyderabad, Telangana, India | |
| Rising Star Elevator Private Limited | ₹52.29 Lakh (FY 2024) | -24.0% | New Delhi, Delhi, India | |||
| Werise Pharmaceutical Private Limited | ₹52.28 Lakh (FY 2025) | 116.0% | Gurgaon, Haryana, India | |||
| Luxe Lounge Private Limited | ₹52.22 Lakh (FY 2025) | 183.0% | Rajkot, Gujarat, India | |||
| Fluidcube Technologies Private Limited | ₹52.2 Lakh (FY 2024) | Pune, Maharashtra, India | ||||
| Merimna Pharma India Private Limited | ₹52.16 Lakh (FY 2025) | 118.0% | Nilambur, Kerala, India |
To see the full peer comparison of Lalvin Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lalvin Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lalvin Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Lalvin Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Lalvin Pharma Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Aryan Raza was appointed as Director on 01 Dec 2023.
Frequently asked questions
Lalvin Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in specialty, within the trading industry. It was incorporated on 31 May 2021 (5+ years old) and is registered under CIN U51909TG2021PTC151869.
Lalvin Pharma has 2 current directors:
- Vinay Kumar - Director
- Aryan Raza - Director
The latest financial statements of Lalvin Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Lalvin Pharma is U51909TG2021PTC151869. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lalvin Pharma was incorporated on 31 May 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Lalvin Pharma by revenue are Mod Steel Trade Private Limited, Tradetrail International Private Limited, Rayanna Sheep and Goat Farmers Producer Company Limited, Aren Capsules Private Limited, Red Sand Holidays Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Aryan Raza was appointed as Director on 01 Dec 2023. Uma Devi ceased to be Director on 01 Dec 2023. Vinay Kumar was appointed as Director on 31 May 2021.
The registered office of Lalvin Pharma is at Plot No – 31 D Tripura Landmark 2 Bowrampet, Hyderabad, Telangana, India – 500043.
Lalvin Pharma operates in the trading industry, in the specialty segment.
Lalvin Pharma can be reached at its registered office: Plot No – 31 D Tripura Landmark 2 Bowrampet, Hyderabad, Telangana, India – 500043.
Lalvin Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.

